Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
June 01, 2021

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Journal for ImmunoTherapy of Cancer
Read more >
CTD²
June 01, 2021

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation*

Cancer Discovery
Read more >
CTD²
May 27, 2021

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages

Cell
Read more >
CTD²
May 20, 2021

Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling

Cell Chemical Biology
Read more >
CTD²
May 15, 2021

The Panorama of Cancer Genetics

Cancer Res.
Read more >
CTD²
May 01, 2021

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

Genome Research
Read more >
CTD²
April 01, 2021

Targeting BET proteins BRD2 and BRD3 in combination with PI3K-AKT inhibition as a therapeutic strategy for ovarian clear cell carcinoma

Molecular Cancer Therapeutics
Read more >
CTD²
March 04, 2021

An expanded universe of cancer targets*

Cell
Read more >
CTD²
March 01, 2021

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype

Journal of Thoracic Oncology
Read more >
CTD²
February 15, 2021

MEK inhibition remodels the immune landscape of mutant KRAS tumors to overcome resistance to PARP and immune checkpoint inhibitors

Cancer Research
Read more >

Pages

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated: February 02, 2023

Content on this page maintained by the Office of Cancer Genomics

CSVXML